Walleye Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.88M | Sell |
|
|||||
|
2024
Q4 | $2.27M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.43M | Buy |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q3 | $562K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $220K | Sell |
|
|||||
|
2022
Q3 | $2.16M | Sell |
|
|||||
|
2022
Q2 | $2.01M | Buy |
|
|||||
|
2022
Q1 | $946K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $202K | Sell |
|
|||||
|
2020
Q1 | $159K | Buy |
|